[3H]Naloxone binding in the human brain: Alcoholism and the TaqI A D2 dopamine receptor polymorphism

Brain Research

Volumn 718, Issue 1-2, 1996, Pages 193-197

  Ritchie, Terry ^a   Noble, Ernest P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcoholism; Caudate nucleus; Dopamine D2 receptor gene; Frontal cortex; Naloxone; Opiate receptor

Indexed keywords

DOPAMINE 2 RECEPTOR; NALOXONE; OPIATE RECEPTOR; DNA; NARCOTIC ANTAGONIST;

ALCOHOLISM; ALLELE; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR BINDING; BRAIN; FEMALE; GENETIC POLYMORPHISM; GENETICS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ALCOHOLISM; ALLELES; BRAIN; DNA; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID;

EID: 0029665177     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00068-6     Document Type: Article

References (42)

1. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, American Psychiatric Association, Washington, 1987.
2. Benjamin, D., Grant, E.R. and Pohorecky, L.A., Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats, Brain Res., 62 (1993) 137-140.
3. 2 dopamine receptor A1 allele, Behav. Genet., 25 (1995) 45-58.
4. Blanchard, S.G., Chang, K.J. and Cuatrecasas, P., Characterization of the association of tritated enkephalin with neuroblastoma cells under conditions optimal for receptor down regulation, J. Biol. Chem., 258 (1983) 1092-1097.
5. Chang, K.-J., Hazum, E., Killian, A. and Cuatrecasas, P., Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide, Mol. Pharmacol., 20 (1981) 1-7.
6. Chang, K.-J. and Cuatrecasas, P. Multiple opiate receptors, enkephalins and morphine binding to receptors of different specificity, J. Biol. Chem. 254 (1979), 2610-2618.
7. Charness, M.E., Quermit, L.A. and Diamond, I., Ethanol increases the expression of functional delta-opioid receptors in neuroblastoma × glioma NG108-15 hybrid cells, J. Biol. Chem., 261 (1986) 3164-3169.
8. 2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat, Mol. Brain Res., 19 (1993) 318-322.
9. 3H-opiates to brain membranes, Life Sci., 33 (1983) 725-733.
10. Gianoulakis, C., The effect of ethanol on the biosynthesis and regulation of opioid peptides, Experientia, 45 (1989) 428-435.
11. 5 enkephalin in mouse brain, Life Sci., 33 (1983) 2331-2337.
12. 125I]epidepride, Brain Res., 609 (1993) 237-243.
13. Koob, G. and Bloom, F.E., Cellular and molecular mechanisms of drug dependence, Science, 242 (1988) 715-723.
14. Kubota, Y., Inagaki, S., Kito, S., Tagaki, H. and Smith, A.D., Ultrastructural evidence of dopaminergic input to enkephalinergic neurons in rat neostriatum, Brain Res., 367 (1986) 374-378.
15. Kuhar, M.J., Pert, C.B. and Synder, S.H., Regional distribution of opiate receptor binding in monkey and human brain. Nature, 245 (1973) 447-450.
16. Le, A.D., Poulos, C.X., Quan, B. and Chow, S., The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in restricted access paradigm, Brain Res., 630 (1993) 330-332.
17. 1 dopamine receptor gene, Proc. Natl. Acad. Sci. USA, 88 (1991) 4205-4209.
18. Le Moine, C., Normand, E., Guitteny, A.F., Fouque, B., Teoule, R. and Bloch, B., Dopamine receptor gene expression by enkephalin neurons in rat forebrain, Proc. Natl. Acad. Sci. USA, 87 (1990) 230-234.
19. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
20. Lucchi, L., Rius, R.A., Govoni, S. and Trabucchi, H., Chronic ethanol induces changes in opiate receptor function and in metenkephalin release, Alcohol, 2 (1985) 193-195.
21. 2 antagonists, Neuroscience, 25 (1988) 525-532.
22. Myers, R.O., Borg, S. and Mossberg, R., Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey, Alcohol, 3 (1986) 383-386.
23. 2 dopamine receptor gene: a review of association studies in alcoholism, Behav. Genet., 23 (1993) 119-129.
24. 2 dopamine receptor A1 allele, Am. J. Hum. Genet., 54 (1994) 658-668.
25. 2 dopamine receptor gene with receptor binding characteristics in alcoholism, Arch. Gen. Psychiatry, 48 (1991) 648-654.
26. 2 dopamine receptor gene and obesity, Int. J. Eating Disord., 15 (1994) 205-217.
27. Normand, E., Popovici, T., Fellman, D. and Bloch, B., Anatomical study of enkephalin gene expression in the rat forebrain following haloperidol treatment, Neurosci. Lett., 83 (1987) 232-236.
28. Normand, E., Popovici, T., Onteniente, B., Fellman, D., Piatier-Tonneau, D., Auffray, C. and Bloch, B., Dopamine neurons in the substantia nigra modulate proenkephalin A gene expression in rat striatal neurons, Brain Res., 439 (1988) 39-40.
29. O'Malley, S.S., Jaffe, A.J., Chang, G., Schottenfeld, R.S., Meyer, R.E. and Rounsaville, B., Naltrexone and coping skills therapy for alcohol dependence: a controlled study, Arch. Gen. Psychiatry, 49 (1992) 881-887.
30. Pfeiffer, A., Pasi, A., Mehraein, P. and Herz, A., Opiate receptor binding sites in human brain, Brain Res., 248 (1982) 87-96.
31. Pickel, V.M., Chan, J. and Sesack, S.R., Cellular basis for interactions between catecholaminergic afferents and neurons containing Leu-enkephalin-like immunoreactivity in rat caudate-putamen nuclei, J. Neurosci. Res., 31 (1992) 212-230.
32. Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. and Erlich, H.A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science, 239 (1988) 487-491.
33. Seizinger, B.R., Bovermann, K., Maysinger, D., Hollt, V. and Herz, A., Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary, Pharmacol. Biochem. Behav., 18 (1983) 361-369.
34. 3H-methionine enkephalin, an opioid peptide, Eur. J. Pharmacol., 47 (1978) 319-331.
35. 2 receptor mRNA in the adult rat striatum, Brain Res., 621 (1993) 249-259.
36. Swift, R.M., Whelihan, W., Kuznetzov, O., Buonigiorno, G. and Hsuing, H., Naltrexone-induced alterations in human ethanol intoxication, Am. J. Psychiatry, 151 (1994) 1463-1467.
37. Tempel, A., Gardner, E.L. and Zukin, R.S., Neurochemical and functional correlates of naltrexone-induced opiate receptor upregulation, J. Pharmacol. Exp. Ther., 232 (1985) 439-444.
38. 2 receptor gene, Trends Neurosci., 16 (1993) 83-88.
39. Volpicelli, J.R., Alterman, A.I., Hayashida, M. and O'Brien, C.P., Naltrexone in the treatment of alcohol dependence, Arch. Gen. Psychiatry, 49 (1992) 876-880.
40. Volpicelli, J.R., Ulm, R.R. and Hopson, N., Alcohol drinking in rats during and following morphine injections, Alcohol, 8 (1991) 289-292.
41. Widdowson, P.S. and Holman, R.D., Ethanol-induced increase in endogenous dopamine release may involve endogenous opiates, J. Neurochem., 59 (1992) 157-163.
42. Wild, K.D. and Reid, L.D., Modulation of ethanol-intake by morphine: evidence for a central site of action, Life Sci., 47 (1990) PL49-54.